BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1039 related articles for article (PubMed ID: 16160738)

  • 1. Identification of osteopenic women at high risk of fracture: the OFELY study.
    Sornay-Rendu E; Munoz F; Garnero P; Duboeuf F; Delmas PD
    J Bone Miner Res; 2005 Oct; 20(10):1813-9. PubMed ID: 16160738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rate of forearm bone loss is associated with an increased risk of fracture independently of bone mass in postmenopausal women: the OFELY study.
    Sornay-Rendu E; Munoz F; Duboeuf F; Delmas PD
    J Bone Miner Res; 2005 Nov; 20(11):1929-35. PubMed ID: 16234965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disc space narrowing is associated with an increased vertebral fracture risk in postmenopausal women: the OFELY Study.
    Sornay-Rendu E; Munoz F; Duboeuf F; Delmas PD;
    J Bone Miner Res; 2004 Dec; 19(12):1994-9. PubMed ID: 15537442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictive value of low BMD for 1-year fracture outcomes is similar for postmenopausal women ages 50-64 and 65 and Older: results from the National Osteoporosis Risk Assessment (NORA).
    Siris ES; Brenneman SK; Miller PD; Barrett-Connor E; Chen YT; Sherwood LM; Abbott TA
    J Bone Miner Res; 2004 Aug; 19(8):1215-20. PubMed ID: 15231007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Type I collagen racemization and isomerization and the risk of fracture in postmenopausal women: the OFELY prospective study.
    Garnero P; Cloos P; Sornay-Rendu E; Qvist P; Delmas PD
    J Bone Miner Res; 2002 May; 17(5):826-33. PubMed ID: 12009013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alterations of cortical and trabecular architecture are associated with fractures in postmenopausal women, partially independent of decreased BMD measured by DXA: the OFELY study.
    Sornay-Rendu E; Boutroy S; Munoz F; Delmas PD
    J Bone Miner Res; 2007 Mar; 22(3):425-33. PubMed ID: 17181395
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contribution of bone mineral density and bone turnover markers to the estimation of risk of osteoporotic fracture in postmenopausal women.
    Garnero P; Delmas PD
    J Musculoskelet Neuronal Interact; 2004 Mar; 4(1):50-63. PubMed ID: 15615078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The FRAX tool in French women: How well does it describe the real incidence of fracture in the OFELY cohort?
    Sornay-Rendu E; Munoz F; Delmas PD; Chapurlat RD
    J Bone Miner Res; 2010 Oct; 25(10):2101-7. PubMed ID: 20499352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clodronate reduces vertebral fracture risk in women with postmenopausal or secondary osteoporosis: results of a double-blind, placebo-controlled 3-year study.
    McCloskey E; Selby P; Davies M; Robinson J; Francis RM; Adams J; Kayan K; Beneton M; Jalava T; Pylkkänen L; Kenraali J; Aropuu S; Kanis JA
    J Bone Miner Res; 2004 May; 19(5):728-36. PubMed ID: 15068495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of clinical risk factors in elderly women with low bone mineral density to identify women at higher risk of hip fracture: The EPIDOS prospective study.
    Dargent-Molina P; Douchin MN; Cormier C; Meunier PJ; Bréart G;
    Osteoporos Int; 2002 Jul; 13(7):593-9. PubMed ID: 12111021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between pretreatment bone resorption and vertebral fracture incidence in postmenopausal osteoporotic women treated with risedronate.
    Seibel MJ; Naganathan V; Barton I; Grauer A
    J Bone Miner Res; 2004 Feb; 19(2):323-9. PubMed ID: 14969403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Residual lifetime risk of fractures in women and men.
    Nguyen ND; Ahlborg HG; Center JR; Eisman JA; Nguyen TV
    J Bone Miner Res; 2007 Jun; 22(6):781-8. PubMed ID: 17352657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Postmenopausal bilateral oophorectomy is not associated with increased fracture risk in older women.
    Antoniucci DM; Sellmeyer DE; Cauley JA; Ensrud KE; Schneider JL; Vesco KK; Cummings SR; Melton LJ;
    J Bone Miner Res; 2005 May; 20(5):741-7. PubMed ID: 15824846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low bone mineral density and fracture burden in postmenopausal women.
    Cranney A; Jamal SA; Tsang JF; Josse RG; Leslie WD
    CMAJ; 2007 Sep; 177(6):575-80. PubMed ID: 17846439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Osteoporosis and fracture risk in women of different ethnic groups.
    Barrett-Connor E; Siris ES; Wehren LE; Miller PD; Abbott TA; Berger ML; Santora AC; Sherwood LM
    J Bone Miner Res; 2005 Feb; 20(2):185-94. PubMed ID: 15647811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between changes in BMD and nonvertebral fracture incidence associated with risedronate: reduction in risk of nonvertebral fracture is not related to change in BMD.
    Watts NB; Geusens P; Barton IP; Felsenberg D
    J Bone Miner Res; 2005 Dec; 20(12):2097-104. PubMed ID: 16294263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bazedoxifene reduces vertebral and clinical fractures in postmenopausal women at high risk assessed with FRAX.
    Kanis JA; Johansson H; Oden A; McCloskey EV
    Bone; 2009 Jun; 44(6):1049-54. PubMed ID: 19254788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for clinical fractures among postmenopausal women: a 10-year prospective study.
    van Geel TA; Geusens PP; Nagtzaam IF; van der Voort DJ; Schreurs CM; Rinkens PE; Dinant GJ
    Menopause Int; 2007 Sep; 13(3):110-5. PubMed ID: 17785036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Skeletal effects of raloxifene after 8 years: results from the continuing outcomes relevant to Evista (CORE) study.
    Siris ES; Harris ST; Eastell R; Zanchetta JR; Goemaere S; Diez-Perez A; Stock JL; Song J; Qu Y; Kulkarni PM; Siddhanti SR; Wong M; Cummings SR;
    J Bone Miner Res; 2005 Sep; 20(9):1514-24. PubMed ID: 16059623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low dietary riboflavin but not folate predicts increased fracture risk in postmenopausal women homozygous for the MTHFR 677 T allele.
    Yazdanpanah N; Uitterlinden AG; Zillikens MC; Jhamai M; Rivadeneira F; Hofman A; de Jonge R; Lindemans J; Pols HA; van Meurs JB
    J Bone Miner Res; 2008 Jan; 23(1):86-94. PubMed ID: 17725378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 52.